
Orca Bio is a late-stage biotechnology company specializing in high-precision cell therapies for cancer and autoimmune diseases. Utilizing single-cell precision, Orca Bio develops proprietary products that replace diseased blood and immune systems with healthy ones, aiming to revolutionize allogeneic cell therapy. Led by a team of leading scientists, engineers, and clinicians, the company is dedicated to transforming patient lives without compromising on efficacy.
Orca Bio is a biotechnology company developing next-generation cell therapies with the goal of improving survival rates and reducing risks associated with blood cancer transplants. The Director of Scientific Communications will lead strategic planning for scientific communication, training, and publications, ensuring the company effectively communicates its science and builds trust with the medical community.
Orca Bio is a late-stage biotechnology company specializing in high-precision cell therapies for cancer and autoimmune diseases. Utilizing single-cell precision, Orca Bio develops proprietary products that replace diseased blood and immune systems with healthy ones, aiming to revolutionize allogeneic cell therapy. Led by a team of leading scientists, engineers, and clinicians, the company is dedicated to transforming patient lives without compromising on efficacy.
Coherus BioSciences